News Agency
The Times

Hanmi Pharmaceutical's Combination Drug for Dyslipidemia Treatment, 'Rosuzet': Confirmed Non-inferiority Efficacy and Safety Compared to Monotherapy in 'The Lancet' 'European Heart Journal'

  • Written by PR Newswire
Hanmi Pharmaceutical's Combination Drug for Dyslipidemia Treatment, 'Rosuzet': Confirmed Non-inferiority Efficacy and Safety Compared to Monotherapy in 'The Lancet' 'European Heart Journal'

SEOUL, South Korea, March 17, 2023 /PRNewswire/ -- Hanmi Pharmaceuticals (128940.KS), a subsidiary of Hanmi Science (008930.KS) in Korea, announced that the results of large-scale clinical trial with Rosuzet have been published in 'The Lancet' and the 'European Heart Journal'.

R&D-oriented pharmaceutical company, Hanmi Pharmaceutical's...

Read more: Hanmi Pharmaceutical's Combination Drug for Dyslipidemia Treatment, 'Rosuzet': Confirmed...

Shotcrete Concrete: How Professional Application Supports Strong Construction

Shotcrete is a method of placing concrete by spraying it at high velocity onto a prepared surface. Shotcrete concrete can be used in projects where access, geometry or site conditions make conventional placement less practical, provided the design and application... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion